280
Participants
Start Date
March 18, 2021
Primary Completion Date
September 18, 2025
Study Completion Date
September 18, 2026
Sirolimus drug-eluting coronary balloon catheter
Patients in experimental group will undergo PCI, using sirolimus drug-eluting coronary balloon catheter.Subjects without stent implantation were regularly treated with dual antiplatelet for 9 months after surgery. Subjects with stents were regularly treated with dual antiplatelet for 12 months after the surgery, in accordance with the applicable guidelines for percutaneous coronary intervention.
Paclitaxel drug-eluting coronary balloon catheter
Patients in control group will undergo PCI, using paclitaxel drug-eluting coronary balloon catheter.Subjects without stent implantation were regularly treated with dual antiplatelet for 9 months after surgery. Subjects with stents were regularly treated with dual antiplatelet for 12 months after the surgery, in accordance with the applicable guidelines for percutaneous coronary intervention.
RECRUITING
Zhongshan Hospital, Fudan University, Shanghai
Shenzhen Salubris Pharmaceuticals Co., Ltd.
INDUSTRY